CoChat

Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination

Castanheira, Mariana, Deshpande, Lalitagauri M., Messer, Shawn A., Rhomberg, Paul R., Pfaller, Michael A. · 2020 · International Journal of Antimicrobial Agents
Cited by 105

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

We evaluated the activity of echinocandins, azoles, and amphotericin B against Candida spp. isolates and characterised azole resistance mechanisms in Candida parapsilosis and Candida tropicalis. Invasive Candida spp. isolates (n = 2936) collected in 60 hospitals worldwide during 2016-2017 were susceptibility tested by CLSI broth microdilution methods. Azole-resistant C. parapsilosis and C. tropicalis were submitted to quantitative RT-PCR for ERG11, CDR1, and MDR1 and the whole genome sequence was analysed. Results of nonsusceptibility to the echinocandins ranged from 0.0-2.3% and was highest in Candida glabrata. Greater than 99.0% of the Candida albicans isolates were susceptible to both fluconazole and voriconazole. Fluconazole resistance in C. glabrata was 6.5% overall and was highest in the United States (13.0%). Resistance to voriconazole in Candida krusei was only noted in the United States (5.0%). Azoles inhibited 89.1-91.6% of C. parapsilosis isolates, and most resistant isolates were noted in Europe (15.1%), including 36 isolates from Italy (3 hospitals) of which 34 harboured Erg11 Y132F mutations and overexpressed MDR1. Azole non-wild-type C. tropicalis (7/227) were from 5 countries: 3 isolates from Thailand had the same Y132F Erg11 alteration. Fluconazole non-wild-type isolates were noted among 3/77 (3.9%) Candida dubliniensis, 4/17 (23.5%) Candida guilliermondii, 4/47 (8.5%) Candida lusitaniae, and other less common yeast species. Echinocandin use has been recommended over fluconazole for invasive Candida infections; however, azoles are still active against the most common Candida spp., and resistance seems to be restricted to certain geographic regions and associated to Erg11 Y132 alterations in C. parapsilosis and C. tropicalis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ijantimicag.2019.09.003

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 105

Metadata

Authors
Castanheira, M., Deshpande, L. M., Messer, S. A., Rhomberg, P. R., & Pfaller, M. A.
Venue
International Journal of Antimicrobial Agents
Publisher
Elsevier BV
Published
2020-01
Volume
55
Issue
1
Pages
105799
ISSN
0924-8579 (ISSN-L)
OpenAlex
W2972480491
Cited by
105
References
20
FWCI
6.69
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination. https://app.cochat.ai/papers/10.1016/j.ijantimicag.2019.09.003
The paper
Castanheira, M., Deshpande, L. M., Messer, S. A., Rhomberg, P. R., & Pfaller, M. A. (2020). Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination. International Journal of Antimicrobial Agents. https://doi.org/10.1016/j.ijantimicag.2019.09.003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.